Predict your next investment

Venture Capital
cardinalpartners.com

See what CB Insights has to offer

Investments

96

Portfolio Exits

24

Funds

5

Partners & Customers

1

Service Providers

1

About Cardinal Partners

Cardinal Partners is a venture capital firm focused exclusively on healthcare investing. The firm specializes in early stage financing rounds, usually as the lead investor in the initial financing round of a growth company.

Cardinal Partners Headquarter Location

230 Nassau Street

Princeton, New Jersey, 08542,

United States

609.924.6452

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Cardinal Partners News

Evli teams up with The Cardinal Partners Global to collaborate in the Netherlands

Sep 7, 2020

(EET/EEST) Evli Fund Management Company Ltd has signed a co-operation agreement with The Cardinal Partners Global for the selling of Evli funds to institutional investors in the Netherlands. The Cardinal Partners Global company offers its strategic advisory services to asset managers for the planning and implementation of their international growth strategies, in addition to the selling and marketing of investment products as a third-party distribution channel with decades of experience. “We’ve been mapping the Dutch market for professional, institutional investors for a long time, and we are delighted to work with an experienced and capable partner in this new market. As a long-standing boutique asset manager in the Nordic region, we want to offer Dutch investors new, successful solutions that go beyond the mainstream and add value and genuine diversification to the portfolio,” says Kim Pessala, Evli's Head of Institutional Clients. “Dutch investors demand that responsibility (ESG) factors are taken into account in their investments, and we at Evli have put a heavy emphasis in ESG over the last decade. This applies to all investment activities as well as our innovation in responsible investment products. I am therefore very pleased that we are now able to offer Dutch institutional investors our new spearhead product, the Evli Green Corporate Bond fund,” Pessala adds. The corporate bond focus of the Evli Green Corporate Bond fund is rare. Very few European green bond funds are dedicated solely to the corporate bond segment, many also invest in government risk. Investing in the green bond market via corporate bonds offers investors several advantages. Asset allocation is more efficient with more specified products. Moreover, the corporate sector plays a key role in developing a greener economy. Therefore, it is of high importance for the investor community to directly support the transformation of these companies when they are investing in projects advancing transition to low-carbon economy and social projects financed with green and sustainability bonds. Also, Evli's crossover approach enables it to seize interesting investment opportunities which are also responsible. “We are delighted with our new partnership with Evli. It’s great to be able to offer Dutch investors interested in responsibility both Evli’s strong ESG capabilities and its unique corporate bond expertise. This adds value while also diversifying the portfolios of Dutch professional investors,” The Cardinal Partners Global’s Managing Director John Birch states. Evli's corporate bond funds are managed by a fixed-income team with a successful history of more than 20 years in the European fixed income market and long, local expertise in the Nordic corporate bond market, which includes unrated corporate bonds. In addition to the Evli Green Corporate Bond Fund, responsibility is integrated into the portfolio management investment process in all of Evli’s funds. Evli signed the Principles for Responsible Investment (PRI) already in 2010 and has since then actively invested in the development of responsible investment. In 2019, Evli published its climate principles and raised responsibility to one of its strategic focus areas. For more information: Kim Pessala, Head of Institutional Clients, Evli Fund Management Company Ltd, tel. +358 9 4766 9141,  kim.pessala@evli.com Evli Bank Plc Evli is a bank specialized in investments that helps institutions, corporations and private persons increase their wealth. The product and service offering includes mutual funds, asset management and capital markets services, alternative investment products, equity research, the administration of incentive programs and Corporate Finance services. The company also offers banking services that support clients' investment operations. Evli is the highest ranked and most used institutional asset manager in Finland*. Evli has a total of EUR 12.9 billion in client assets under management (net 6/2020). Evli Group's equity capital totals EUR 71.8 million and its BIS capital adequacy ratio is 15.3 percent (June 30, 2020). The company has around 250 employees. Evli Bank Plc's B shares are listed on Nasdaq Helsinki Ltd. *KANTAR SIFO Prospera External Asset Management Finland 2015, 2016, 2017, 2018, 2019 and SFR Scandinavian Financial Research Institutional Investment Services, Finland 2015, 2016, 2017, 2018. Distribution: main media, www.evli.com

Cardinal Partners Investments

96 Investments

Cardinal Partners has made 96 investments. Their latest investment was in Vividion Therapeutics as part of their Series B on April 4, 2019.

CBI Logo

Cardinal Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/30/2019

Series B

Vividion Therapeutics

$82M

No

7

4/8/2019

Series B

Prealize

$22M

No

3

10/5/2017

Private Equity - IV

Brighton Health Group

$0.13M

Yes

1

9/27/2017

Series A

Subscribe to see more

$99M

Subscribe to see more

10

3/17/2017

Series E

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/30/2019

4/8/2019

10/5/2017

9/27/2017

3/17/2017

Round

Series B

Series B

Private Equity - IV

Series A

Series E

Company

Vividion Therapeutics

Prealize

Brighton Health Group

Subscribe to see more

Subscribe to see more

Amount

$82M

$22M

$0.13M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

3

1

10

10

Cardinal Partners Portfolio Exits

24 Portfolio Exits

Cardinal Partners has 24 portfolio exits. Their latest portfolio exit was Ivenix on March 31, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/31/2022

Acquired

$99M

6

9/14/2021

Acquired

$99M

1

8/5/2021

Acquired

$99M

13

8/19/2020

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

10/1/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/31/2022

9/14/2021

8/5/2021

8/19/2020

10/1/2019

Exit

Acquired

Acquired

Acquired

Acq - P2P

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

6

1

13

10

10

Cardinal Partners Fund History

5 Fund Histories

Cardinal Partners has 5 funds, including CHP IV - Warehouse.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/15/2019

CHP IV - Warehouse

$1.76M

1

2/5/2008

CHP III LP

Subscribe to see more

Subscribe to see more

$99M

10

4/13/2001

CHP II LP

Subscribe to see more

Subscribe to see more

$99M

10

10/1/1997

CHP I LP

Subscribe to see more

Subscribe to see more

$99M

10

CHP IV LP

Subscribe to see more

Subscribe to see more

10

Closing Date

4/15/2019

2/5/2008

4/13/2001

10/1/1997

Fund

CHP IV - Warehouse

CHP III LP

CHP II LP

CHP I LP

CHP IV LP

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$1.76M

$99M

$99M

$99M

Sources

1

10

10

10

10

Cardinal Partners Partners & Customers

1 Partners and customers

Cardinal Partners has 1 strategic partners and customers. Cardinal Partners recently partnered with Optima Health on June 6, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

6/17/2019

Partner

United States

Cardinal Analytx and Optima Health Enter into Multiyear Strategic Alliance to Improve Care and Reduce Costs. Integrated Health System Will Leverage Cardinal Analytx's AI-enabled Health Insights to Identify Potential High-Risk Members for Early Intervention and Proactive Care.

Our partnership with Cardinal Analytx extends this leadership , enabling us to fundamentally change how we deliver healthcare and truly begin solving for population health , '' said John Coughlin , vice president , Informatics and Analytics at Optima Health .

1

Date

6/17/2019

Type

Partner

Business Partner

Country

United States

News Snippet

Cardinal Analytx and Optima Health Enter into Multiyear Strategic Alliance to Improve Care and Reduce Costs. Integrated Health System Will Leverage Cardinal Analytx's AI-enabled Health Insights to Identify Potential High-Risk Members for Early Intervention and Proactive Care.

Our partnership with Cardinal Analytx extends this leadership , enabling us to fundamentally change how we deliver healthcare and truly begin solving for population health , '' said John Coughlin , vice president , Informatics and Analytics at Optima Health .

Sources

1

Cardinal Partners Service Providers

1 Service Provider

Cardinal Partners has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

Partnership data by VentureSource

Cardinal Partners Team

5 Team Members

Cardinal Partners has 5 team members, including current General Partner, Kent Marquardt.

Name

Work History

Title

Status

Kent Marquardt

General Partner

Current

Thomas G. Mckinley

General Partner

Current

William Perilli

Controller

Former

Brandon H. Hull

Edison Partners

Managing General Partner

Former

Lisa Skeete Tatum

Harvard Business School, Cornell University, GE Capital, and Procter & Gamble

General Partner

Former

Name

Kent Marquardt

Thomas G. Mckinley

William Perilli

Brandon H. Hull

Lisa Skeete Tatum

Work History

Edison Partners

Harvard Business School, Cornell University, GE Capital, and Procter & Gamble

Title

General Partner

General Partner

Controller

Managing General Partner

General Partner

Status

Current

Current

Former

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.